Table S1 from PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
Bo Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center), Dimitrios Korentzelos(University of Pittsburgh Medical Center), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Wenhui Wu(Shanghai Pulmonary Hospital), Paul G. Corn(Cornell University), Michael T. Tetzlaff(Hospital of the University of Pennsylvania), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Zhenyang Dong(The University of Texas MD Anderson Cancer Center), Yu Chen(University of Wisconsin System), Guang Yang(Imperial College London), Yong Luo(Guangdong 999 Brain Hospital), Sanghee Park(Hanbat National University), Cheng Wu(Jilin University), Zhe Tang(Zhejiang International Studies University), Likun Li(The University of Texas MD Anderson Cancer Center), Chuandong Geng(Baylor College of Medicine), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Michael Sigouros(Cornell University)
Cited by 0
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k